Description

Wang et al reported a clinical tool for predicting an extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-EB) bloodstream infection in a solid organ transplant recipient. This can help in the selection of initial antibiotic therapy. The authors are from the University of Pennsylvania, Johns Hopkins University, University of Maryland and the University of North Carolina.


Patient selection: solid organ transplant recipient with bloodstream infection (BSI)

 

Parameters:

(1) ESBL-EB organism isolated on a prior culture

(2) E. coli isolated from a prior culture

(3) Enterobacterales organism isolated from prior urinary culture

(4) exposure to third generation cephalosporin in past 6 months

(5) exposure to trimethoprim-sulfamethoxazole in past 6 months

(6) exposure to an aminoglycoside in past 6 months

(7) mechanical ventilation in past 48 hours

(8) hypotension in past 48 hours

(9) receipt of non-corticosteroid immunomodulator in prior 30 days

(10) corticosteroid-containing chronic immunosuppressive regimen at time of BSI

 

Parameter

Finding

Points

ESBL-EB isolate

no

0

 

yes

5

E.coli isolated

no

0

 

yes

-1

Enterobacterales isolated urine culture

no

0

 

yes

-2

third generation cephalosporin exposure

no

0

 

yes

3

trimethoprim-sulfamethoxazole exposure

no

0

 

yes

2

aminoglycoside exposure

no

0

 

yes

1

mechanical ventilation

no

0

 

yes

2

hypotension

no

0

 

yes

1

non-corticosteroid immunosuppression

no

0

 

yes

2

corticosteroid-containing immunosuppression

no

0

 

yes

2

 

total score =

= SUM(points for all of the parameters)

 

Interpretation:

• minimum score: -3

• maximum score: 18

• The higher the score the greater the risk.

• A score >= 2 had a sensitivity of 0.7 and specificity of 0.8. The PPV was 0.5 and NPV 0.9.

 

Performance:

• The area under the ROC curve is 0.81.


To read more or access our algorithms and calculators, please log in or register.